ClinicalTrials.gov
public full text
Public Domain
A Study of [14C]-LY4064809 in Healthy Participants
The purpose of this study is to determine in healthy participants the percentage of LY4064809 that enters bloodstream after oral administration. Blood tests will be performed to investigate how the body processes the study drug. For each participant, the study will last about 21 days, not including screening. Participants will remain in the clinical research center for 14 days.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of LY3867070 in Healthy Participants#910615
- A Study of LY3819469 in Healthy Participants#1101501
- Study to Compare 2 Formulations of LY900014 in Healthy Participants#841692
- A Study of Multiple Doses of LY3305677 in Healthy Participants#993158
- A Study of LY3819253 (LY-CoV555) in Healthy Participants#845480
Record · ID 897195
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive